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Postpartum depression (PPD) is depression that occurs in women following childbirth occurring 
during the postpartum period and affects 1 in 7 women (The United States Preventive Services 
Task Force, 2019). The American Academy of Pediatrics [AAP] (2019), recommends that 
pediatric healthcare providers utilize their position to screen for PPD. The purpose of this 
evidence-based practice (EBP) project was to implement a PPD screening intervention within a 
pediatric healthcare setting using the Edinburgh Postnatal Depression Scale (EPDS). The 
Academic Center for Evidence-Based (ACE) Practice Star Model guided this EBP project with 
evidence-based interventions developed after a comprehensive literature search. 
Implementation of the EBP project occurred in a pediatric office in northeast, Indiana in which 
eligible mothers were screened at their child’s 1, 2, 4, and 6-month well-child visits. A total of 30 
participants were screened for risk for PPD at their child’s initial well-child visit and then 12 
weeks later with a follow-up phone call. Interventions to increase awareness of PPD were 
delivered to participants based on their EPDS scores. Participants scoring greater than 10 were 
identified as highest risk for PPD and were provided with community resources, PPD 
educational information, and a referral to their obstetrician/gynecologist (OB/GYN), or primary 
care provider (PCP). Those who scored less than 10 received community resources and PPD 
educational information to review at their convenience. A 12-week follow-up phone call was 
conducted for all participants post-intervention. A paired-samples t-test indicated a significant 
decrease from pre-intervention EPDS total score was found t(29) = 6.625, p < .001.  The mean 
of the pre-intervention EPDS score was 4.83 (4.65) and the mean of the pre-intervention 
OB/GYN or PCP follow-up was 2.67 (0.76). A significant decrease from the pre-intervention 
EPDS score to follow-up was found t(29) = 2.259, p < 0.05. A one-way between subjects’ 
ANOVA was conducted to compare the effect of past medical history on EPDS total scores. 
There was a significant effect of past medical history on EPDS total scores at the p < .05 level 
for the three conditions F(4, 25) = 3.121, p = 0.033.







According to the United States Preventive Services Task Force [USPSTF] (2019), 
postpartum depression (PPD) is depression that occurs in women after childbirth, it affects as 
many as 1 in 7 women and is the most common within the postpartum period. Symptoms for 
postpartum depression include “loss of interest and energy, expressed mood, fluctuations in 
sleep or eating patterns, reduced ability to think or concentrate, feelings of worthlessness, and 
recurrent suicidal ideation” (USPSTF, 2019, p. 1). These symptoms can have negative short 
and long-term effects not only for mothers but also for their children (USPSTF, 2019, p.1).  
Women who suffer from PPD exhibit significantly higher levels of negative and lower levels of 
positive behavior toward their child (i.e. praising or playing with their child), increase 
breastfeeding cessation, receive fewer preventive health services (i.e. vaccinations), and 
influence the child’s cognitive and emotional development with an increased risk for psychiatric 
disorders in their children (USPSTF, 2019).  
 The Centers for Disease Control and Prevention (CDC) identify potential risk factors that 
are associated with the development of postpartum depression. These risk factors include 
experiences that may affect mothers’ moods, for instance, “stressful live events, low social 
support, family history of depression, being a teen mom, mom of multiples, history of 
depression, preterm delivery, pregnancy complications, birth complications and having a baby 
that is hospitalized” (CDC, 2017). Although there are many risk factors that can increase the 
chances of developing postpartum depression, this condition can occur within a healthy 
pregnancy, or in women who experienced a normal birth and delivery of a healthy baby.  While 
the CDC identifies social experiences that may alter women’s moods increasing their chances 
of having postpartum depression, the USPSTF identifies other contributing risk factors. Risk 
factors such as “low socioeconomic status, lack of support, genetic factors, history of physical or




sexual abuse, unplanned pregnancy, lack of financial support and gestational diabetes” 
(USPSTF, 2019, p.1). These risk factors help providers have a better understanding of their 
patients when screening for postpartum depression.  
 Postpartum depression screening is done using different tools with the most frequently 
reported being the Edinburgh Postnatal Depression Screening (EPDS), Personal Health 
Questionnaire 2 (PHQ-2) or Personal Health Questionnaire 9 (PHQ-9). These screening tools 
help determine how mothers have been coping with their feelings and provide healthcare 
providers with the information they need to properly assess their mental state. 
Data from the Literature Supporting Need for the Project 
 According to the American Academy of Pediatrics [AAP] (2019), 10% of women suffer 
from depression during the postpartum period, but less than half of those cases are recognized. 
Therefore, a screening process for depression is needed to provide opportunities to improve 
outcomes for both mother and child. AAP (2019) recommends that pediatric health care 
providers are in a great position to screen mothers for postpartum depression due to the 
frequent visits that occur in the first year of life for their child. Since these providers are well-
positioned to screen mothers for postpartum depression, AAP recommends integrating a 
screening process at the 1, 2, 4, and 6 months well-child visits. The USPSTF and Centers for 
Medicare and Medicaid Services (CMS) both support PPD screening and supports the 
recognition of screening as an evidence-based recommendation, whereas providers are able to 
close the gap in the rates of PPD screening. As of 2017, the AAP, USPSTF, and CMS 
recognize that PPD screenings measure the risk of the infant’s environment, therefore billing for 
this type of screening conducted during office visits is appropriate. The Current Procedural 
Terminology (CPT) code for post-partum depression screening during well child encounters is 
96161 “Administration of caregiver-focused health risk assessment instrument for the benefit of 
the patient, with scoring and documentation, per standardized instrument” (AAP, 2016, p.1). 




Therefore, screening in a pediatric office is appropriate and the capability for billing and coding 
is indicated.  
Data from the Clinical Agency Supporting Need for the Project 
 The proposed pediatric clinical site in Fort Wayne, IN currently does not screen for 
maternal depression in their office. Furthermore, providers are not consistent in their screening 
methods, documentation of the screening, and subsequently the education and/or referral 
process for those scoring at risk for PPD at this clinical setting. This site is a privately-owned 
medical clinic in which EBP is frequently integrated into practice by the primary medical 
provider. The primary medical provider was interested in implementing a maternal depression 
screening within his office as recommended by the AAP. Most pediatricians in the city of Fort 
Wayne, IN do not screen for postpartum depression (personal communication, medical director, 
April-June 2019). Many providers that do screen for postpartum depression have been 
practicing for years and have had someone implement the screening process within their 
practice for them or are personally interested in the screening process (personal 
communication, medical director, May 2019). The provider at the proposed project site was 
excited for the screenings to be integrated within his practice and was prepared to help in any 
way possible (personal communication, medical director, May 2019). Relationships between 
pediatrician providers and obstetricians (OB) is based on location. Some pediatrician providers 
are linked to the OBs offices and share electronic medical records. This proposed project site 
was not linked to OBs offices and does not share a similar electronic medical record as OB 
offices or hospitals.  
The population presenting to this clinic for care is diverse including a variety of ethnic 
backgrounds including Caucasians, Hispanics, Asians and African Americans. There was 
Spanish speaking office staff available to assist with patients and their families that do not speak 
or interpret English well. The provider believes in holistic treatment and refers to natural 
products as much as possible (personal communication, medical director, May 2019). The 




medical provider at this clinic approaches illnesses will natural safe supplements when 
necessary. The culture of the office is health first, promoting healthy eating and living (Jefferson 
Pediatrics PC, 2014). There is one nurse practitioner (NP) and two physician assistants (PAs) 
that conduct new well-child visits as well as the primary provider. Each provider adheres to the 
office culture of being natural and promoting holistic treatment (Jefferson Pediatrics PC, 2014).     
Purpose of the Evidence-Based Practice Project 
Evidence has demonstrated that maternal depression is prevalent among postpartum 
women and is not being recognized. According to the United Health Foundation and data 
retrieved from the CDC, there was no data reported for the state of Indiana related to the 
incidence of postpartum office visits for women following delivery (2019). Although there was no 
data reported for postpartum visits, the 2018 visits for the well-baby check was 93.1% (United 
Health Foundation, 2019). The pediatric setting has been identified as an avenue for captivating 
the maternal population during the postpartum period, who may otherwise not follow up with a 
provider, thus closing the gap in PPD screening.  The purpose of this EBP project was to 
implement a postpartum depression screening intervention within a pediatric setting using a 
synthesis of current evidence by utilizing the EPDS screening tool to identify depression in 
postpartum women within the first year of their infant’s life. By doing so this minimizes the future 
risk of undiagnosed of depression within postpartum women and negative health consequences 
for their children. Hence, the compelling clinical question that initiated this EBP project was: 
What is the effect of screening women for postpartum depression within a pediatric setting? The 
aims of the project were to increase awareness and recognition of PPD in postpartum women 
up to one year after delivery, which ultimately reduces the rates of undiagnosed women.  
PICOT Question 
 Specifically, this project will address the following PICOT question: “In postpartum 
women (P), how does the implementation of a screening and referral protocol (I) for postpartum 




depression in a pediatric setting affect mental well-being (EPDS scores) (O), as, compared to 
the current practice (C) over a twelve-week period (T)?”. 
Significance of the EBP Project 
 Postpartum depression is common, with potentially life-threatening effects on mother 
and babies during the first year of life. This EBP project seems well-timed since the 
recommendation of screening for PPD in a pediatric setting was reported in 2010 by the AAP. 
Being that maternal depression affects the whole family, it is essential that the gap is closed, 
screening rates increase, and pediatricians recognize the signs of postpartum depression given 
the frequent contact with parents of infants (AAP, 2019).  
“PND (perinatal depression) peaks in women 18 to 44 years of age. In general, as many 
as 12% of all women who are pregnant or in the postpartum period experience depression 
in a given year, and 11% to 18% of women report postpartum depression symptoms. The 
prevalence in women with low income is estimated to be double at 25%”. “Minor 
depression peaks at 2 to 3 months postpartum, and the peak for major depression is at 6 
weeks postpartum” while there is also another peak for depression at the 6-month period 
postpartum (Rafferty et al., 2019, p. 2).  
These peaks of postpartum depression occur after OB visits, therefore the need for continued 
screening is indicated in a different setting such as a pediatric office.  
This EBP project sought to provide additional profundity to the current evidence 
regarding maternal screening for PPD within a pediatric setting. The results may provide 
observable information for providers, patients, and office staff. Pediatrician offices may use the 
findings to revise policies, protocols, and assessments across different pediatrician offices and 
health care settings. The interventions were implemented to increase awareness of postpartum 
depression and close the gap of missed opportunities to address mothers at risk for postpartum 
depression. Protocols were established to aid providers to navigate and intervene based on 
screening results. This ensures consistency of screening across providers at the proposed 




clinic. This protocol also included educational information including a list of resources and 
referral recommendations for mothers (see Appendix G).  Results may be used by other 
advanced practice registered nurses (APRNs) to facilitate maternal care in a pediatric setting 
aiming to increase patient outcomes which ultimately impact family dynamics and family health 
as a whole.  





EVIDENCE-BASED PRACTICE MODEL AND REVIEW OF LITERATURE 
Evidence-based Practice Model 
Overview of EBP Model 
The Academic Center for Evidence-Based Practice (ACE) Star Model was used to aid in 
guiding the development of this EBP project. The ACE Star Model was developed at the 
University of Texas Health Science Center in San Antonio. There are many challenges that 
present when transitioning research into practice, but the ACE Star Model has developed a 
pathway to overcoming these obstacles. “The ACE Star Model explains how to overcome the 
challenges of (1) the volume of research evidence, (2) the misfit between form and use of 
knowledge, and (3) integration of expertise and patient preference into best practice” (Melnyk & 
Fineout-Overholt, 2015, p.305). This model helps aid in the understanding of nature, cycles, and 
knowledge that are used in the different aspects of evidence-based practice. According to 
Stevens (2012), “the Star Model places nursing’s previous scientific work within the context of 
EBP, serves as an organizer for examining and applying EBP, and mainstreams nursing into the 
formal network of EBP” (p. 1).  
The ACE Star Model explains how various forms of knowledge are essential when 
transforming research into practice. For example, the inclusion of systematic reviews and 
clinical practice guidelines are forms of knowledge that can be used as supporting evidence to 
guide EBP initiatives. These various forms of knowledge move through several cycles which 
include a combination of knowledge and integration into practice. The model provides a 
systematic framework for integrating research into practice through five stages of knowledge 
transformation. These stages are (a) discovery research, (b) evidence summary, (c) translation 
to guidelines, (d) practice integration, and (e) process, outcome evaluation (Melnyk & Fineout-
Overholt, 2015). Stevens (2012) states that knowledge transformation is “the conversion of 




research findings from primary research results, through a series of stages and forms to impact 
on health outcomes by way of evidence-based care” (p. 1).   
Application of EBP Model to DNP Project 
Star point one (stage one) of the five-stage process is discovery research. Also known 
as the knowledge-generating stage. During this stage, it is essential to discover what the 
research indicates about the clinical burning question and how EBP projects are developed. For 
this EBP project, this stage included research that supported the lack of implementation of 
proper assessing/screening of postpartum depression and how it affects postpartum mothers. 
The project coordinator initially reviewed single studies that evaluated the effects of screening 
for postpartum depression. This led to the discovery that screening postpartum depression 
within a pediatric setting has not yet been widely implemented across the nation and is 
recommended as a best practice strategy. Although screening for postpartum depression in a 
pediatric setting is supported in the literature, not all pediatric offices are implementing this 
screening process. Thus, the decision to move forward in evaluating further studies regarding 
the implementation of screening postpartum women for postpartum depression within a 
pediatrician clinic emerged. Once the review of further supportive studies occurred, progression 
into the second stage of the ACE Star Model was deemed appropriate.   
Star point two (stage two) of the five-stage process is an evidence summary. This is also 
considered a knowledge-generating stage, where “evidence summaries produce new 
knowledge by combining findings from all studies to identify bias and limit chance effects in the 
conclusions” (Stevens, 2012, p. 1).  For this EBP project, the synthesis of literature essentially 
served as the evidence summary. The use of the critical appraisal of the evidence was used to 
determine what is high quality for use to guide the interventions. Common themes throughout 
the literature such as, type of tool, referral process and incorporation within the practice were 
described. This high-quality evidence guided this EBP project by providing the best 
interventions and recommendations.  




The translation is the star point three (stage three) of the five- stage process. This stage 
actually encompasses two stages, translating evidence into a practice recommendation and 
integration into practice. Essentially, this can be defined as taking the evidence and combining it 
with clinical expertise to implement it into practice. As for this EBP project, there are clinical 
guidelines as well as single research studies being used to support the recommendation. The 
clinical guidelines on implementing postpartum screening within a pediatric setting have been 
developed by the AAP and Association of Women’s Health, Obstetric and Neonatal Nurses 
(AWHONN) which were used to guide this EBP project. Stevens (2012) states “summarized 
research evidence is interpreted and combined with other sources of knowledge and then 
contextualized to a specific client population and setting” (p. 1). For this EBP project, the best 
practice model indicates the targeted population should be postpartum women attending well-
child visits within a pediatric setting.  
The fourth point in the five-stage process is, practice integration, which is considered 
“the most familiar stage in healthcare because of society’s long-standing expectation that 
healthcare is based on the most current knowledge, thus, requiring the implementation of 
innovations” (Stevens, 2012, p. 1). This current knowledge once implemented into practice is 
considered best practice. Relating to this EBP project, the project coordinator facilitated this 
stage by ensuring proper education supporting the need for the project was provided to office 
personnel. For success during this stage, it was essential that the staff and providers bought-in 
and understood the importance of screening and its impact on the child’s health.  Furthermore, 
project recruitment and participation included clear and purposefully detailed information to 
eligible postpartum women highlighting the importance of screening for postpartum depression. 
Interventions were carefully planned so as not to disturb the normal workflow of the office or 
staff within the pediatric project site.  
The last stage (stage five) of the ACE Star Model is evaluation, which includes process 
and outcomes. This stage “is an inclusive view of the impact that the EBP has on patient health 




outcomes, satisfaction, efficacy and efficiency of care, and health policy” (Melnyk & Fineout-
Overholt, 2015, p. 306). According to Stevens (2012), “the final outcome is evidence-based 
quality improvement of health care” (p.1). As knowledge is transformed through each of the five 
stages of the ACE Star Model the final outcome of this EBP project was focused on the health 
of postpartum women and their infants by increasing proper screening for postpartum 
depression. The purpose of this screening strategy within a pediatric setting was to identify PPD 
in women who may have been missed if not screened appropriately during their obstetric visits 
or neglected to follow up with a provider during their postpartum period.  
Strengths and Limitations of EBP Model for DNP Project 
The strengths of the ACE Star Model for this EBP project included its ease of use and 
capability to transition through the five stages. This model aided in the organization and 
interpretation of relevant information to be applicable within the healthcare system. A strength 
the model had was increasing the understanding of the science of EBP. Understanding the 
science of EBP and how clinical practice guidelines can initiate the application of research into 
practice was a key component of this EBP project, which was emphasized in one of the stages 
of the ACE Star Model. The uniqueness of the ACE Star Model’s aim was to create new 
knowledge, while this EBP project aim was to create new knowledge based on the outcomes of 
postpartum depression screening within a pediatric setting.  
There were some limitations of this model, including that the stages of the model were 
intended to be progressed through in a chronological sequence. The model does not appear to 
have a linear effect, rather a circular model, which indicates that the project leader would start 
over or repeat the cycle. The model does not appear to have an ending. When using it for 









Sources Examined for Relevant Evidence 
A search was completed for relevant evidence to identify the benefits of screening for 
PPD within a pediatric setting. The databases that were examined include the Cumulative Index 
to Nursing and Allied Health Literature (CINAHL), Joanna Briggs Institute (JBI), Cochrane 
Library, ProQuest Nursing and Allied Health Source, PsycINFO, and Medline. Support from the 
Valparaiso University health sciences librarian was utilized to narrow and focus key terms based 
on databases searched. The MeSH (medical subject heading) system and Boolean system 
were used in order to keep consistency throughout the different databases. Initial key terms 
used within the literature search prior to coordinating with the librarian included postpartum 
depression, postnatal depression, PPD, pediatrician, pediatrics, pediatrician offices, well child 
visits (WCV). After collaborating with the librarian, the use of MeSH terms and Boolean 
operators were utilized for a more advanced literature search. The best combination of phrases 
and key terms included “postpartum depression” OR “postnatal depression” AND pediatric* OR 
“pediatrician office” OR “well-child visit*”. Abstracts were reviewed that contained these key 
terms or phrases.  
Abstracts were considered for inclusion as supporting evidence for this project if they 
were (a) written in English, (b) peer-reviewed, and (c) published within the last five years 
(between 2014 to 2019). Exclusion criteria for abstracts included (a) those abstracts that were 
conducted outside of the United States, (b) published in different languages (non-English), (c) 
the interventions were not implemented in a pediatric setting,(d) the abstract provided 
background information regarding postpartum depression, knowledge, or attitudes toward and 
definitions, and (e) articles that included a prenatal depression screening. These abstracts were 
eliminated due to the lack of support and applicability to the population of interest.  
 After a complete review of the abstracts and elimination of duplicate citations from the 
searched databases, a total of 14 articles were considered appropriate for the development of 




the EBP project (see Table 2.1). After the systematic search was completed within each 
database, retrieval of the supportive articles of evidence was completed. CINAHL yielded 47 
results with nine articles deemed relevant to the EBP project. Of these nine articles, there was a 
policy statement from the AAP as well as a position JBI database search included simple search 
phrases such as “postpartum depression” OR “postnatal depression” and resulted in 38 articles 
while only one was relevant to the EBP project. The Cochrane Library database search utilizing 
the simple search terms postpartum depression” OR “postnatal depression” yielded 34 results 
with none being relevant to the EBP project. The search within Medline via EBSCO utilized 
MeSH terms combined with Boolean operators (MM’ Postpartum Depression) AND pediatric* 
OR “pediatrician office” OR “well-child visit*” yielded 103 results and after elimination of 
duplicate citations, resulted in one relevant article. Replication of the search terms used within 
Medline yielded two articles from the ProQuest database both of which were relevant and met 
inclusion criteria. The same search, utilizing the MeSH terms and Boolean operators within 
PsycINFO yielded 47 articles and after elimination of duplications, one article was included for 
the EBP project. Five chased citations lead to one pilot study within the Journal of Clinical 
Pediatrics that was deemed relevant to the EBP project.  
Levels of Evidence 
 After the selection of the fourteen articles, it was essential to appropriately evaluate each 
piece of evidence to ensure these articles were relevant and of good quality for the EBP project. 
The Johns Hopkins Nursing Evidence-Based Practice (JHNEBP) Research Evidence Appraisal 
Tool was utilized to evaluate each piece of evidence retrieved for use in the development of this 
EBP project. Within this tool, each piece of evidence was identified by the type of study design 
and appraised using a structured set of questions that assist with rating the research pieces 
evidence according to level (I-V) and quality (A-C).  Level I includes experimental study, 
randomized controlled trials (RCTs), explanatory mixed-method design that includes only a level 
I quantitative study and systematic review of RCTs with or without meta-analysis. Within this 




EBP project, a perspective cohort study was utilized as level I.  Level II includes quasi-
experimental study, explanatory mixed-method design that includes a level II quantitative study, 
systematic review of a combination of RCTs and quasi-experimental studies, or quasi-
experimental studies only, with or without meta-analysis. This EBP project yielded three level II 
articles which included quasi-experimental, pilot study and systematic review.  Level III includes 
nonexperimental study, systematic review of a combination of RCTs, quasi-experimental and 
nonexperimental studies, or nonexperimental studies only, with or without meta-analysis, 
exploratory, convergent, or multiphasic mixed methods studies, explanatory mixed method 
design that includes only a level III quantitative study, qualitative study, and meta-synthesis. An 
appraisal of evidence was utilized as level III within this EBP project. Level IV evidence levels 
include an opinion of respected authorities and/or nationally recognized expert committees or 
consensus panels based on scientific evidence, including clinical practice guidelines, consensus 
panels/position statements. Two recommendation/position statements were used as level IV 
articles in the development of this EBP project.  Level V evidence includes evidence-based on 
experiential and nonresearched evidence, including integrative reviews, literature reviews, 
quality improvement, program or financial evaluation, case reports and opinion of nationally 
recognized experts based on experiential evidence. The level V articles utilized for this EBP 
project included three literature reviews, an evidence summary and three quality improvement 
articles. 
Appraisal of Relevant Evidence 
The JHNEBP Research Evidence Appraisal Tool is designed to lay the foundation “for 
understanding the importance of implementing EBP in a transformed healthcare environment, 
emphasizing the necessity for continuous quality improvement and cost-effectiveness” (Dearholt 
& Dang, 2017, p.xxi). The appraisal tool includes a set of questions for each type of evidence 
retrieved that determines the type, quality, and level of each piece of evidence that is appraised.  




Within this tool, there are evidence rating levels ranging from Level I (highest) to Level V 
(lowest) that are assigned to the pieces of the evidence appraised. Within each level, there is 
also a rating for the individual pieces of evidence categorized as A (high quality), B (good 
quality) or C (low quality/major flaws). The final articles chosen for the EBP project have a 
variety of leveling and quality ratings which helps support the PICOT question and purpose of 
this project. Having lower-rated articles such as can indicate that there was a small sample size 
or that the study was considered a quality improvement project rather than research. Although 
there were some low-quality articles included within the final supportive evidence guiding this 
EBP project, this does not imply that they were not beneficial to project implementation and 
achieving desired outcomes. These articles provided a great foundation for the project purpose 
and diversify the evidence provided. The final literature appraisal included fourteen pieces of 
evidence: four-level I (1-prospect cohort, 1-evidence summary & 2- systematic reviews), two-
level II (quasi-experimental study & pilot study), two-level IV (2- clinical guidelines) and six-level 
V (3- literature reviews & 3- quality improvements) (See Table 2.2). The level of evidence was 
determined using the JHNEBP Research Evidence Appraisal Tool and organized in an evidence 















Table 2.1  











CINAHL 47 0 15 9 




Cochrane 34 5 1 0 
 
MEDLINE 103 15 1 1 
 
ProQuest 2 0 2 1 
 
PsycINFO 155 12 2 1 
 
Chasing 5 0 1 1 
 
Total:    14 
 
Table 2.2 
Levels of Evidence and Quality Grade Table  
Levels of Evidence Number of Articles 
Level I 1 
Level II 3 
Level III 1 
Level IV 2 
Level V 7 
Quality Grade Number of Articles 
A (high quality) 7 
B (good quality) 7 
C (poor quality) 0 
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Level I evidence. 
Emerson, Matthews, and Struwe (2018) conducted a prospective cohort study to 
determine the prevalence of PPD in new mothers during screenings at the 2-, 4- and 6-month 
well-child visit (WCV) in an urban outpatient pediatric, examine feasibility factors relative to 
extending the current standard of care for PPD screenings; and examine visit documentation for 
at-risk mothers. A study was conducted over a 6-month period to gather information regarding 
screenings for new mothers at their 6-month well-child visit. This article was well written and 
organized (grade A). The quality of the prospective cohort study was very well explained and 
detailed. Inclusion criteria included postpartum women (not pregnant), able to read and 
understand English, 19 years or older, and attending the 6-month WCV. There was a clear 
statement of purpose and methods for evaluation were clearly stated. Data collection methods 
were stated clearly, and participants were given consent to participate. The study’s strengths 
and limitations were indicated in the article. The study resulted in forty-three women 
participants, while prevalence rated among participants was 10%, 12.5% and 14% for 2-month, 
4-month, and 6-month visits. Two of the six mothers that were identified to have a positive 
screening did not have a positive screening at the 2- and 4-month visit, while the remaining four 
had a positive screening at the 4-month visit. Concluded that the prevalence of postpartum 
depression among the participants is consistent with previous rates anticipated. The prevalence 
rate of positive EPDS for the 6-month WCV prevalence rates at 14%. The prevalence rate for 
the 2-month WCV was 10% and 12.5% for 4-month WCV. There were 47% of the visits that 
contained documentation of suicide, while treatment options and PPD education was 
documented at 87% of the visits. Screening mothers multiple times throughout well-child visit is 
relevant and beneficial to identify postpartum depression and its persistence. There were some 
mothers who declined screening, which indicates that there is a need to explore the mother’s 
acceptability to be screened. This study implies that in order for screening to be effective among 
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individuals identified with the risk of depression there must be a system in place to ensure 
adequate follow-up.  
Level II evidence. 
 Friedman, Rochelson, Fallar, and Mogilner (2016) conducted a quasi-experimental study 
that examined the effects of educational sessions about postpartum depression and 
modification of the electronic medical record on providers screening for postpartum depression. 
The study was conducted in a pediatric office in East Harlem, where a large population of low-
income patients resided. An educational session was given to the physicians and pre- and post-
surveys compared to comfort and self-reported screening. There were three groups that 
received individual educational sessions regarding postpartum depression and screening. One 
hundred charts were reviewed at three different time periods, prior to the education intervention, 
after the educational intervention but prior to the EMR changes and after EMR changes. Within- 
group 1, none of the mothers documented PPD screenings, group 2, 2 of the 100 (2%) mothers 
were screened and neither screened positive, and group 3, 69 (74%) mothers were screened. 
Within-group 3, the 69 mothers that were screened, seven (10%) screened positive. There was 
a statistically significant difference between the groups. Compliance with providers increased 
after educational pieces were provided. However, some providers felt uncomfortable with 
screening mothers, due to the unfamiliarity of the screening tools and referral process.  “The 
mean score on a test of general knowledge of PPD increased from 55% in the pre-group to 70% 
in the post group who attended the educational conference” (Friedman et al., 2016, p. 795). The 
study concluded that PPD screens are valid and can be integrated within a well-child 
appointment. The increase of knowledge allows pediatricians to have a better understanding of 
the screening tools and its use, which essentially increases the actual screenings.  This article 
was well written and concise (grade B). The purpose was clearly stated, and data was 
presented clearly throughout the article.  
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 Leis et al., (2014), conducted a pilot study that integrated an evidence-based preventive 
intervention into a pediatric primary care clinic. The study took place in a low-income urban 
community. The standard of care in this clinic included mothers bringing their infants for 
newborn, 2-, and 4-month well-child visits was to meet with the clinical social worker for an 
assessment of maternal health status and associated stressors using the USPSTF 2-item 
depression screener. The inclusion criteria for this study included women who were 
experiencing depressive symptoms and exclusion criteria included psychosis or significant 
mental health impairment. After the selection of women for participation, two cohorts 
participated in the MB Course. The MB Course is an intervention that uses cognitive-behavior 
therapy approach to the management of moods by incorporating social learning concepts. 
These concepts help reduce depressive symptoms. The intervention included 6 weekly, 2-hour 
sessions. These 6 sessions were divided into 3 modules: (1) promoting pleasant activities, (2) 
reducing harmful thought patterns and increasing helpful thought process and (3) promoting 
social support. There was a total of 15 women who participated in the study, who enjoyed 
participating in the study. Participants who attended a vast majority of the sessions showed 
higher levels of engagement and accepted the intervention format and content presented.  The 
findings of this study indicated that implementing an evidence-based preventive intervention for 
PPD in a pediatric primary care setting serving this particular population was successful. This 
study was written clearly and appropriately (grade B). Authors clearly identified possible 
outcomes and limitations to the study.  
Van der Zee-van den Berg, Boere-Boonekamp, IJzerman, Haasnoot-Smallegange and 
Reijneveld (2016) conducted a systematic review investigating the evidence of the effectiveness 
of screening for postpartum depression in well-baby care settings, regarding mother and child 
outcomes. The inclusion criteria and articles selected for review had great quality and were 
assessed with the Quality Assessment Tool for Quantitative Studies. Some inclusion criteria 
included women up to 12 months postpartum, screening using a valid screening instrument and 
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articles written in English, Dutch, German or French. While some exclusion criteria include 
studies with no control group to compare effectiveness, screening using a non-validated 
instrumented, screening during pregnancy only and articles not written in other languages. From 
these 3,033 articles screened six articles were selected. The article was well written and 
organized (grade A) and the selected articles were explained in great detail. These six studies 
were evaluated within this systematic review, of these six studies, two were rated strong pieces 
of evidence and four were rated weak. The six selected articles range from a variety of study 
designs, two being pre- and post- design with no blinding, one quasi-experimental and three 
RCTs. After the assessment of the articles using the Quality Assessment Tool for Quantitative 
Studies, overall the authors reported the articles to be strong to weak. From the studies, there 
were four studies that supported the use of screening and enhancing care for postpartum 
women. There were small sample sizes that made the evidence found relevant but not 
significant, therefore higher-quality studies are needed to strengthen the evidence regarding the 
benefits of screening in a well-baby care setting according to this review. Within this review, 
multiple databases were searched, identified and details of the studies were presented. The 
review was well written, and information flowed logically, and conclusions were based on the 
results of the studies.  
Level III evidence.  
Waldrop, Ledford, Perry, and Beeber (2018) conducted an appraisal on current evidence 
on implementing screening for postpartum depression within a pediatric primary care setting. 
After a search in multiple databases using inclusion criteria such as dated after 2010 and 
implementation of PPD screening in a pediatric primary care setting while exclusion criteria 
included studies done outside of the United States, from this search a total of seven studies 
were selected. These seven studies included one RCT, three quasi-experimental, two quality 
improvement and one qualitative study. There were three screening tools used within these 
studies, the Edinburgh Postnatal Depression Scale (EPDS), PHQ-2 and PHQ-9. The screening 
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tool was provided during the intake process and a range of 27.8% to 78.8% of participants 
completed the questionnaires. Within this appraisal, a description of the use of an algorithm for 
screening is described and having supportive resources as well as a referral process in place 
for practice. The authors of this appraisal identified the use of a clinical decision support 
algorithm for screening and how its use is effective within the pediatric setting. “Using a decision 
support algorithm that a pediatric primary care practice can adapt to fit its setting and needs is a 
good place to start” (Waldrop et al., 2018, p.e70).  This review concluded that the evidence 
supporting the implementation and evaluation of PPD screening in a pediatric setting was 
effective. The evidence was evaluated using the Grading of Recommendation Assessment, 
Development and Evaluation (GRADE) criteria. These GRADE criteria measured the evidence 
as moderate to low. This appraisal resulted in that screening for postpartum depression was 
feasible to do at the local level. The purpose of this review was clearly stated and well written 
(grade A). The search terms were clearly stated, and databases were indicated, the inclusion 
and exclusion criteria were stated within the review and the flow of the studies reviewed was 
concise.   
Level IV evidence.  
 Rafferty, Earls, Yogman, and Mattson (2019) provided a screening recommendation 
from the AAP stating that providers should screen women for maternal depression at well-child 
visits. “Pediatric medical homes can establish a system to implement screening and to identify 
and use community resources for the further assessment and treatment of the mother with 
depression as well as for the support of the mother-child dyad” (Rafferty et al., 2019, p. 3). AAP 
policy states there is much support for primary care pediatricians to incorporate these 
approaches for implementing these screenings. The recommendations include the use of a 
validated screening tool for maternal depression during well-child visits at 1, 2, 4 and 6 months. 
There are also recommendations for follow up, referral processes and treatment options for 
providers to follow to ensure the best patient outcomes are available for all patients. Within the 
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statement, there are examples and resources for the providers to consider for their patients.  
The clinical practice guideline is well written and relays information concisely (grade A). 
Information is sponsored by a professional organization and has consistent and clear 
recommendations. Utilizing clinical practice guidelines within the EBP project strengthens the 
project and its support of implementation.  
The AWHONN (2015) authored a position statement on mood and anxiety disorders in 
pregnant and postpartum women. The statement recommends universal screening of all 
pregnant and postpartum women for mood and anxiety disorders. Healthcare facilities that 
serve pregnant women, new mothers, and newborns should have policies and protocols that 
address screening and education for women and mechanisms for staff training regarding these 
disorders.  It is recommended that registered nurses are in key positions to recognize and 
perform screenings to help identify at-risk women. Nurses can do so by providing initial effective 
interventions, improving access to community-based resources and being the gap between 
patients and healthcare providers. This position statement was well written and relayed 
information concisely (grade B). This statement provides strength to the EBP project by 
positively informing individuals of the need and importance of screening. With the support of a 
professional organization, its recommendations are clear and specific.  
Level V evidence.  
Gyi (2018) conducted an evidence summary based on postpartum depression and the 
best assessment tool for screening. This evidence summary based on a structured search of 
the literature and steams from clinical practice guidelines, a systematic review and 
observational studies. Guidelines recommend health professionals perform a routine 
assessment of the emotional and wellbeing of women, while the systematic reviews assess the 
accuracy of screening tools. These systematic reviews indicated that EPDS was the most 
accurate and valid tool for screening. According to Gyi (2018), it is recommended that all health 
care professionals involved with the care of the patient should assess for postpartum 
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depression. Gyi (2018) provides a detail explanation of the proper assessment of postpartum 
depression using the EPDS and the identification of scores. Individuals who score 10, 11 or 12 
should be reassessed within 2-4 weeks and support services increased. Those individuals who 
score 13 or 14 should be referred to an appropriate health professional. While individuals 
scoring 15 or more should have access to a mental health assessment and management 
immediately. Those individuals who score 1, 2, or 3 on question 10 should be assessed for the 
safety of self as well as children in care.  Gyi (2018) provides best practice recommendations for 
health professionals to follow in order to care for postpartum women appropriately and 
effectively. This evidence summary is written clearly and organized (grade A), recommendations 
were clear, types of evidence were included, and literature was up to date. The evidence 
obtained was consistent with other high-level studies and the source of information was 
credible.  
Gilbert, Balio, and Bauer (2017) summarized the current literature regarding the 
responsibilities of providers, liabilities, and perspectives of providers within a pediatric setting 
screening for postpartum depression screening. Gilbert, Balio and Bauer (2017) stated “the 
guidelines call for (1) maximizing benefits while minimizing burdens (2) assessing the likelihood 
of effectiveness, voluntariness of the interventions and distribution justice; (3) respecting patient 
and parent autonomy, privacy and confidentially; (4) considering the responsibility and liability of 
the provider; and (5) seeking input from all stakeholders “ (p. 269).  The authors noted that there 
is a burden placed on caregivers when screening is done alone. It is ethically imperative that 
mothers who screen positive have an appropriate follow-up process for the support of both the 
mother and infant. For pediatricians, there is a fiduciary duty to provide care for the children 
beyond the child due to children not having the capability to speak for themselves and having 
legal guardians. The literature supports a variety of terms in which the healthcare provider is 
responsible to ensure patients are receiving the best care possible. These terms include 
beneficence, non-maleficence, autonomy, informed consistency, confidentiality, privacy, utility, 
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and distributive justice. Each of these terms was discussed within the literature and how 
pediatricians have a legal obligation to provide the best care for their patients, which extends 
beyond the actual patient themselves. Medical liability plays an important role in appropriate 
care being given to patients. It hinges on if a provider is practicing responsible and consistent 
with the standard of care. Screening mothers in a pediatric setting can be argued that the 
pediatricians have an ethical responsibility to care for the mother who is caring for their patient.  
The literature supports the use of a valid tool to screen postpartum women for postpartum 
depression. The most common tool used for identifying symptoms was the EPDS and the PHQ-
2 or PHQ-9. Within these supporting literatures there is a strong legal and ethical case 
supporting the implementation of a universal screening for PPD in a pediatric primary care 
setting using validated tools when informed consent can be obtained and appropriate follow-up 
services available and accessible.  This review of the literature is well written and described the 
aims in great detail (grade A/B). The strengths, limitations and future implications were 
expanded upon clearly and concisely. There was no bias reported in the literature review noted.        
 Kurtz, Levine, and Safyer (2017) conducted a literature review addressing the concerns 
of implementing postpartum screening within a pediatric primary care setting. Kurtz et al., (2017) 
provide information regarding types of postpartum mood and anxiety depressive disorders 
(PMADs), such as depression, baby-blues, postpartum depression, anxiety and postpartum 
psychosis, and how they can impact an infant. The impact and management of each depressive 
disorder are based on the severity of the mothers’ symptoms. The baby-blues seem to affect 
between 15% to 85% of new mothers, while postpartum depression affects 10-20% of mothers. 
Postpartum anxiety disorders affect between 11% to 21% of women while postpartum psychosis 
occurs as high as 30%-50% of women. These depressive disorders are common postpartum 
and can occur up to 1 year postpartum. These depressive disorders have different impacts on 
the infant’s life based on the severity of the mothers’ symptoms, mothers with PMADs tend to 
have lower levels of maternal sensitivity which can be neglected for the infant. PMADs have a 
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negative impact on the mother-infant relationship which leads to a dysfunction of infant 
development. Implementation of screening for postpartum depression is based on the individual 
characteristics of the pediatric office setting. There are recommendations based on AAP, Bright 
Futures, DC Collaborative for Mental Health in Pediatric Primary care and the Society for 
Developmental and Behavioral Pediatrics (SDBP) Workgroup and state legislations.  Kurtz et al. 
(2017) recommend the Plan-Do-Study-Act (PDSA) cycle to implement practice change following 
the evaluation of the special needs of each pediatric clinic setting.  Screening mothers using the 
EPDS, PHQ-2, and PHQ-9 was recommended based on the pediatric setting environment. The 
study concluded that it is possible to implement the screening program within each practice to 
better serve mothers and infants. The study was written well and reviewed the current literature 
appropriately (grade B).  
 Olin et al., (2017) reviewed literature that suggested that there are specific strategies to 
aid in the implementation of screening for postpartum depression within a pediatric setting. The 
authors produced a stepped care approach to caring for screening and managing postpartum 
depression. Step 1 included screening for depressive symptoms using either rather EPDS or 
PHQ-9 to screen mothers in a pediatrics setting beginning at the 2-month well-baby visit through 
the 6-month well-baby visit. These early screening measures can lead to early treatment of 
postpartum depression. Step 2 included psychosocial risk assessment to understanding the 
contributing factors leading to PPD. Targeting these contributing factors can aid in the 
development of the support needed by pediatric providers. A risk assessment tool can be used 
to assess perinatal risk for depression in primary care settings, which aids in the development of 
screening tools postpartum. Step 3 detailed care management based on the risk profile for 
women who fall in the middle section of the care pathway, with moderate levels of depression 
symptoms. These women benefit from supportive interventions that can be integrated within the 
well-child visit. Step 4 provided guidance for follow-up and monitoring of PPD, suggest following 
up at the 6-month well-care visit for individuals who are high risk and that periodic reassessment 
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is included, which entails life events that can affect maternal and child well-being. Maternal 
depression can last up to one year postpartum, if unaddressed. Recognizing PPD risk factors 
during well-child visits is important for continuous monitoring.  
This stepped care approach includes systematic screening for depression symptoms, 
and a systematic risk assessment for women who screen positive and care management based 
on risk profiles and responsiveness. The literature concludes that the proposed pathway 
(stepped care) is a testable model that can be integrated into a pediatric setting to improve child 
well-being. There are challenges in implementing screenings in pediatric settings such as lack 
of confidence and in effectively managing mothers, lack of reimbursement, social and 
environmental factors, lack of supportive interventions, concerns of confidentiality and sensitivity 
and provider documentation. These challenges are real but not insuperable. The review of 
literature is well written, and information is relayed concisely (grade A/B).    
Mgonja and Schoening (2016) implemented a quality improvement project to implement 
and evaluate a postpartum depression screening program utilizing the EPDS within a pediatric 
setting. During well-child appointments up to one year of age, mothers were screened for 
postpartum depression at a private, faith-based primary care clinic in the Midwest. The authors 
used the Plan-Do-Study-Act (PDSA) framework to guide their project. The EPDS was given to 
mothers (ages 19 years or older) at well-child appointments, and results reviewed frequently to 
incorporate protocol changes as necessary. Developing a care plan for mothers scoring of 10 or 
higher was termed triage care and considered a positive result. There were a total of 35 
mothers screened over 9 weeks. Staff compliance, which was calculated weekly, was 78.7% of 
administering the screening tool, there were a total of 10 (21.3%) missed opportunities. Mothers 
that were screened ranged from ages 20-34 years, while the infant ages range between 2 
weeks to 12 months. Results indicated that there were five positive EPDS screenings during this 
project implementation. The study concluded that screening mothers during well-child 
appointments is appropriate and if not done is a missed opportunity for providers. This study 
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supports the use of implementing a screening tool within a pediatric setting to identify PPD at 
well-child visits up to one year of age. This quality improvement project was written clearly and 
examines the workflow and processes of incorporating the screening tool into a pediatric setting 
(grade A). The aim of the project was stated clearly, and results were described and interpreted 
clearly.  
Puryear, Nong, Correa, Cox, and Greeley (2019), conducted a quality improvement 
project that increases access to perinatal mental health services through a universal screening 
tool for postpartum depression and facilitating referrals for evaluation and treatment at a multi-
site, integrated system of pediatric and obstetric practices in Houston, TX. Women were 
screened with the EPDS twice during pregnancy and at 6 weeks postpartum by their obstetric 
provider and at their infant’s 2 weeks, 2-, 4- and 6-month at well-child visits by pediatricians. 
Women with a score of 10 or higher or women who reported thoughts of self-harm were offered 
a referral to a mental health provider. A total of 102,906 women were screened over a four-year 
period. Of those, 6,487 (6.3%) screened positive and with 3,893 (3.8%) referred for treatment. 
From those referred for treatment, 2,172 (55.8%) women made an appointment with a mental 
health provider within 60 days of the referral. 170 positive screens resulted in 185 (108.8%) 
referrals with 153 (82.7%) appointments completed for one obstetric practice. The obstetric 
practices with collocated referral model, 1,489 positive screens resulted in 2,222 (149.2%) 
referrals with 1,702 (76.6%) completed appointments. The pediatric practice with adjacent 
lactation of women’s clinic, 220 positive screens resulted in 96 (43.6%) referrals and 39 (40.6% 
appointments completed. While the remaining pediatric practices had 4,608 positive screens 
resulting in 1,390 (30.2%) referral sand 278 (20.0%) completed appointments. This quality 
improvement project indicated with adequately trained staff and systematic planning that PPD 
can be screened within both obstetric and pediatric practices and high screening and referral 
rates can be achieved. This quality improvement was well written and relayed information 
clearly (grade A). The aim of the project, strengths, limitations and results were clearly stated.   
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Sorg, Coddington, Ahmed and Richards (2019) conducted a quality improvement project 
to improve standardized screening for postpartum depression for a 3-month period in the 
pediatric care setting in a rural federally qualified health care center (FQHC) in north-central, 
Indiana. There were secondary aims to determine if infant and family characteristics were 
associated with positive postpartum depression screening. This implementation of the EPDS 
screening tool occurred at 1,2 and 6-month WCC visits and was evaluated by independent 
samples t-test and logistic regression for data analysis. The EPDS was administered by the 
nurse or medical assistant (MA), and then the PCP reviewed the results and implemented the 
next step based on the score. The results were recorded in the electronic medical record (EMR) 
by the nurse or MA, and the EMR scored the completed EPDS. This quality improvement 
project was based on the PDSA framework and showed a slightly significant increase in PPD 
screening practices with improvement from 83% to 88% (p= 0.096).  This project indicated that 
mothers who were screened at 1-month well child check (WCC) visits had higher rates than 
mothers screened at 2 or 6- month WCC visits. Demographics such as male gender, Medicaid 
and Hispanic ethnicity had a higher likelihood of positive screenings. Mothers who bottle-fed 
versus exclusively breastfeed had a lower likelihood of positive screenings. Monthly income 
affected positive screening rates, whereas mothers who earned less than $2,000 a month had 
higher positive screening rates. This quality improvement project indicated that pediatric health 
care providers can effectively screen for PPD and certain infant and family characteristics might 
alert the provider to a higher risk for mothers. This quality improvement project was well written 
and provided clearly stated aims and results (grade B). There was no bias reported in the 
project.  
Construction of Evidence-based Practice 
Synthesis of Critically Appraised Literature 
 The appraisal of these fourteen relevant pieces of literature specified a deeper 
understanding of implementing a screening protocol for PPD within a pediatric setting. Studies 
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that were used within the appraised literature disclosed findings and recommendations for 
practice in direct response to this project’s PICOT question. The literature evidence supporting 
this project revealed comparable findings and recommendations for best practice (See Table 
2.2). The use of the EPDS (intervention) to screen postpartum women presenting to the 
pediatric setting for their infant’s well-child visits (population) was supported in the literature as 
an effective way to identify PPD (outcome) in pediatric settings up to six months after delivery 
(timeframe).  
 Population. The literature was divided when deciding to measure depression either in a 
pediatric setting or an obstetric setting. The underlying goal across all of the studies was to 
increase the use of PPD screening in a pediatric setting. All of the guidelines suggested 
measuring depression prenatally and postpartum or anytime when in contact with a perinatal 
mother (AWHONN, 2015; Gyi, 2018; Fafferty et al., 2019). With the assessment of mothers 
postpartum, many studies implemented a protocol for measuring PPD within an urban setting to 
explore any acceptability and outcomes (Friedman et al., 2016; Leis et al., 2015). While there 
was implementation across urban settings, the literature did support implementing a protocol 
within all pediatric areas, rather urban, rural, heavy populated or not (Puryear et al., 2019; Kurtz 
et al., 2017; Gilbert et al., 2017; Olin et al.).  
 Interventions. The literature appraised suggested that there was an intervention tool that 
would be best for use in a pediatric setting to screen for postpartum depression. A simple 10- 
item self-report questionnaire, the EPDS was provided to all the patients who met criteria to be 
screened prior to seeing the provider (Gyi, 2018; Emerson et al., 2018; Olin et al., 2017; Kurtz et 
al., 2017; van der Zee-van den Berg et al., 2016; Waldrop et al., 2018; Sorg et al., 2019; 
Puryear et al., 2019; Mgonja & Schoening, 2016). The evidence suggests that this screening 
tool is the most effective and valid. Some pediatricians opted to utilize different screening tools 
in combination with the EPDS such as the PHQ-2 or PHQ-9 (Waldrop et al., 2018; van der Zee-
van den Berg et al., 2016; Kurtz et al., 2017; Gilbert et al., 2017; Olin et al., 2017).  
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Length of intervention. The length of the intervention varied from eight weeks to four to 
six months. The screening process for mothers had some consistency throughout most of the 
studies, typically including  screening at 2, 4 and 6 month well-child visits with some variations, 
based on pediatric visits (Emerson et al., 2018; Olin et al., 2017; van der Zee-van den Berg et 
al., 2016; Sorg et al., 2019; Puryear et al., 2019; Mgonja & Schoening, 2016). In addition, the 
length of the intervention did not extend past 6 months due to 6 months being the peak of when 
women experience PPD.  
Best Practice Model Recommendation 
 The best practice model recommendation developed for this EBP project was 
synthesized from the most current, best available and critically appraised evidence. Postpartum 
women are not currently screened effectively due to the limited amount of time they visit with 
their obstetrician. Women have only one or two postpartum visits with their obstetrician which is 
a narrow window for screening, while “a pediatric primary care provider sees a mother as 
frequently as eight times within the first 6 months of her child’s life, placing pediatric providers in 
a strategic position to screen for PPD” (Waldrop et al., 2018, p.e68).  Henceforth, postpartum 
depression can negatively affect the mother’s engagement with others. “Postpartum depression 
impacts not only the mother, but it also affects the family, most notably the infant. Untreated 
PPD is associated with lower rates and shorter duration of breastfeeding, poor maternal-child 
bonding, child and infant developmental delays and poor mental health outcomes in childhood” 
(Sorg et al., 2019, p.84). Therefore, screening for postpartum depression in a pediatric setting 
creates a destigmatizing opportunity for providers to ensure measures are being taken to 
properly screen for mood disorders, closing the gap of mothers being overlooked for screenings. 
Consequently, screening mothers in a pediatric setting using the EPDS was created as an EBP 
project to link current evidence to practice and potentially impact all postpartum mothers during 
well-child visits. This program was developed in a pediatric setting in a patient-friendly format 
that can easily be implemented in other pediatric settings and aligns with recommendations 
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from AAP, USPSTF, AWHONN, CMS, and National Association of Pediatric Nurse Practitioners 
(NAPNAP). This author proposed that implementing the best practice model, You’re Not 
Forgotten, would demonstrate that mothers participating in the screening process in a pediatric 
setting would demonstrate positive shifts in knowledge and attitudes about post-partum 
depression and seek treatment for postpartum depression following the program intervention.   
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CHAPTER 3 
IMPLEMENTATION OF PRACTICE CHANGE  
Implementation of an evidence-based protocol including the use of a PPD screening tool 
for the identification of postpartum depression in mothers visiting a pediatric office for well-child 
visits was considered best practice by the current body of evidence reviewed in the literature. 
Multiple expert organizational recommendations and position statements support this universal 
practice change including the AAP, USPSTF, AWHONN, CMS, and NAPNAP. Therefore, this 
evidence-based protocol was initiated as a result of an identified need and supportive evidence 
demonstrating positive outcomes.  The EBP project included the project coordinator’s 
collaboration with pediatric office providers and staff who appreciate and value the significance 
of practice change to improve patient outcomes. This EBP project aimed to help identify 
postpartum depression in women who may not follow up with their obstetrician during the 
postpartum period and/or were not screened appropriately in the obstetric setting when 
returning for care post-delivery. The purpose of this project was to improve the identification 
rates of postpartum depression by implementing a postpartum depression screening in a 
pediatric setting during well-child visits.  
Participants and Setting 
  The conduction of the EBP project took place in a pediatric office setting located in Fort 
Wayne, Indiana that provides primary care services to patients across the lifespan of newborns 
to early adulthood up to the age of 21. The pediatric office providers consisted of a double 
board-certified pediatrician (MD), office manager, secretaries, a pediatric nurse practitioner 
(NP), two physician assistants (PAs) and medical assistants (MAs) which will be a part of the 
practice change. The project coordinator has never been employed by this facility, which aided 
in eliminating the potential of selection bias. Written permission for the project’s implementation 
was granted on June 19, 2019, by the facility’s office manager after discussion with the primary 
physician of the practice, who was in full support of the project’s goals for practice change. Key 
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stakeholders at the project site supported that the project would be beneficial for the patient 
population, was feasible for the location of the facility, and staff within the clinic had a vested 
interest in the project outcomes.  
 Participants eligible for participation in the project were mothers of infants recruited 
during their well-child visit appointments at the 1, 2, 4 and/or 6-months visits at the pediatric 
health center from September of 2019 to November of 2019. The secretaries’ role in the project 
was to review patient charts at check-in to determine initial eligibility based on the type of visit. 
Participants were postpartum women attending well-child visits that were 18 years or older that 
have the ability to understand spoken and written English. Spanish assessment tools were 
provided for patients whose primary language was Spanish but understood English.  
 Mothers with a positive history of depression, including currently being treated for 
depression with pharmacological management, cognitive therapy and/or any homeopathical 
alternatives were eligible for participation but this was disclosed upon the initial patient survey 
questionnaire collected during recruitment. The decision to include these participants was made 
by the project coordinator and site facilitator because it was determined that excluding these 
patients would limit the sample size.  
Pre-Intervention Group Characteristics 
 Participants eligible to participate were adult women, 18 years of age or older regardless 
of race or socioeconomic status, presenting to the pediatric site during the months of September 
to November of 2019 for their infant’s well-child visits. The participants were English and 
Spanish speaking individuals, however, those individuals that spoke Spanish, had to 
comprehend English in order to participate. The inclusion criteria included postpartum women, 
attending well-child visits between 1, 2, 4, and 6 months at the pediatric health clinic. While 
exclusion criteria included individuals under the age of 18, non-English speaking adults, and 
males (fathers).  These participants were excluded from the project due to the inability to 
complete the activities required of the project.   
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Intervention 
   After reviewing the recommendations from good and high-quality pieces of evidence, 
the EBP project intervention was developed based on these best practice recommendations. 
The most reliable and consistently recommended PPD screening tool to implement in the 
pediatric setting was the EPDS. The literature supported the effectiveness of using this 
screening tool to help providers identify the risk for postpartum depression. Each eligible 
participant that consented to participate in the EBP project received an informed consent (see 
Appendix D), a recruitment letter including a description of the project participant questionnaire 
and the EPDS screening via paper and pencil format. Samples of the recruitment letter with the 
project introduction is presented in Appendix D and the participant questionnaire is presented in 
Appendix F.  After the consent was signed and the screening tool results calculated by the 
secretarial staff or medical assistants at the project site, the numerical results (ranging from 0-
10+) of the EPDS was recorded in the patient’s EMR by the secretaries or medical assistants in 
the PPD screening section of the chart for the provider to access during the well-child visits. All 
participants with a score of less than 10 on the EPDS resulted in participants receiving 
information regarding postpartum depression in the form of an educational handout (see 
Appendix F) and provider discussion as documented in the EMR. A score of 10 or greater on 
the EPDS resulted in participants receiving information regarding postpartum depression in the 
form of an educational handout and provider discussion, a list of community resources, as well 
as referral to their obstetrician or primary care provider for further management and care. When 
present in the clinical setting, the project coordinator was available to answer questions that any 
participants had regarding the project, while it was the responsibility of the providers within the 
clinic to provide education and discuss the results of the screening tool with mothers during 
well-child visits. The project coordinator reviewed the health records of participants to track 
scores at each visit, ensured documentation and adherence to educational handouts and 
discussions by providers as well as resource lists and referrals within the community. The 
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project coordinator conducted calls to all mothers that scored 10 or higher within 2 weeks of 
their visit to track compliance with follow-up to referrals. A 12-week follow-up phone call was 
made to re-evaluate all participants EPDS scores. A review of records as well as patient 
schedules to evaluate missed opportunities and declination of participation by mothers asked to 
sign consent was also conducted.  
Comparison  
  The AAP recommends that pediatricians close the gap and initiate screening mothers 
for maternal depression during well-child visits. Screening mothers at the first six well-child visits 
increases the chance of a mother disclosing postpartum depression symptoms. The provider is 
able to see consistencies in scores while tracking her progress within the electronic health 
record.  Compared to the current standard of care consisting of no routine or standardized 
screening, documentation, education, or distribution of community resources or referral at the 
pediatric health clinic, this project implementation adheres to best practice optimal mother and 
baby outcomes. 
Outcomes 
  Multiple outcomes of the EBP project were measured based upon the supporting 
literature. The primary outcome measured was the effectiveness of the identification of risk for 
postpartum depression in postpartum women using the EPDS in a pediatric setting during well-
child visits. While the secondary outcomes measures including demographic characteristics, 
different variables that could potentially affect EPDS scores and pre- and post-intervention 
EPDS scores in relations to follow up.   
The secretaries were responsible for checking patients in and distributing the project 
introduction letter, screening tool, and participant questionnaire. While the MAs were 
responsible for the calculation and entering of the EPDS scores in the EMR. The providers were 
responsible for the reviewing of scores and discussion/education patients and to distribute 
educational handouts and resources/referral lists. The project coordinator was responsible for 
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conducting follow up phone calls with participants scoring 10 or greater within 2 weeks to 
monitor compliance with referral follow up. The project coordinator also called all participants for 
a post intervention EPDS score at 12 weeks.  The project coordinator was responsible for 
reviewing chart records to track maternal EPDS score trends with WCC visits, missed 
opportunities, declination of participation and provider adherence/documentation of score 
review, discussion, education and referral as appropriate based on score.  
Evaluation of the reported answers and referral process was based on best practice. 
EPDS is a user-friendly tool that takes approximately 2- 5 minutes to complete with 10 
questions presented with options in a Likert scale format. This Likert scale consists of each 
question that can earn up to 3 points. The mother was asked to check the response that comes 
closest to how she has been feeling in the previous seven days. There was a maximum score of 
30 points. Scores ranging from 0-9 received PPD information and resources, scores 10 or 
greater received a referral as well as resources and any mother scoring a 1, 2 or 3 to question 
10 about suicidal ideation was assessed by the provider and referred out for immediate 
assistance.  Possible risk for depression was indicated with a score of 10 or greater, while 
scores above 13 were likely to be suffering from a depressive illness of varying severity. This 
screening tool provided the provider with a clear picture of the patient’s mental health status 
over the 7 days preceding the well-child visit. The AAP does not endorse or approve any 
specific tool for screening purposes but provides a resource for providers to use to select a 
screening tool from screeningtime.org. This AAP (2019) authored website offers a variety of 
resources to assist providers with the screening process for maternal depression, 
developmental concerns, and social determinants of health. The EPDS tool has 86% sensitivity 
and 78% specificity and can be completed in five minutes or less and scored three minutes or 
less (AAP, 2019). Data was collected before the participant saw the provider upon check-in for 
the appointment at the receptionist desk. Once signed in, the secretary or project coordinator 
provided the mother presenting for 1, 2-, 4-, and 6-month child visits with a project packet 
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including an introductory letter about the project, consent form, participant questionnaire, and 
EPDS screening tool. Once the data form was collected by the MA, the total score and score for 
question 10 were calculated with a key (see Appendix F) and results were recorded in the EMR 
for the provider to see with a prepopulated algorithm to guide provider interventions. After the 
results were recorded, patient names were removed from the form, a unique identifier was 
assigned for data analysis and subsequent visit tracking and the form were kept in a secure 
lockbox on site. The project coordinator collected forms weekly to properly analyze the data.   
Measurement. Frequencies and descriptive statistics were conducted to evaluate the 
demographics of mothers and their scores on the form, the credentials of certain providers (NP, 
PA, or MD) and their adherence to documentation, discussion, etc. with patients about their 
EPDS scores. A paired sample t-test was conducted to evaluate the EPDS scores prior to 
implementation and 12 weeks post-intervention.  
Time 
 This EBP project was implemented from September 3rd through November 26th of 2019 
based on the recommendations from the project site facilitator and correlating academic session 
of the University in which the project coordinator was enrolled. These dates were prior to the 
winter months, in which staff and/or patients and families may take a vacation, inclement 
weather could increase the likelihood of missed appointments and holidays may have impacted 
the office hours of the clinic. Literature shows that data can be collected anywhere between 8 
weeks to 6 months (Kurtz et al., 2017; Rafferty et al., 2019; Sorg et al., 2019; Emerson et al., 
2018). Proper implementation of this intervention required at least 60 days which was 
recommended by the project facilitator and office staff. This timeframe ensured that staff were 
adaptive to the changes and incorporated the PPD screening recommendation within their daily 
routines. Planning for this timeframe requires staff education and training, printing preparations, 
EMR familiarity, templating, and staff participation.   
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Protection of Human Subjects 
 The protection of human subjects was maintained throughout the EBP project. The 
project coordinator was educated regarding the protection of human subjects and successfully 
completed an ethics course within the Valparaiso University Doctor of Nursing Practice (DNP) 
curriculum in the fall semester of 2017. Online training was also completed through the 
Collaborative Institutional Training Initiative (CITI) in April of 2019. A certificate of completion of 
the CITI course is available in Appendix B. The project coordinator received approval from the 
Valparaiso University Institutional Review Board (IRB) through an exempt review as a quality 
improvement project on July 21, 2019. Consent was obtained from participants (see Appendix 
D) and a thorough written explanation of the project, including the risks, commitment, and 
benefits, was provided to each participant. Confidentiality was also upheld, and participants 
were made aware that participation was solely voluntary. No pressure or coercion was involved 
for participation. The data collected was kept in a secured and private location and identifiable 
information was removed from the form with unique identifiers assigned for data tracking and 











You’re Not Forgotten was developed to provide an evidence-based approach to aid 
pediatric healthcare providers in identifying the risk of postpartum depression in women who 
were attending well child visits with their infants. This approach helped identify women who may 
have gone unscreened from missed visits with their PCP or OB/GYN during the postpartum 
period. To address the issue, the project coordinator developed a 12-week EBP project. The 
EBP project was designed to determine if screening mothers for PPD using a standardized tool 
in a pediatric setting would better identify those at risk of developing PPD. This would promote 
earlier pediatric provider screening and treatment interventions for women with PPD who could 
possibly be missed otherwise. Primary patient outcomes, including the depression screening 
scores were measured via the EPDS over a 12-week period. Secondary outcomes, including 
participant demographics, variables that could potentially affect EPDS scores, and the pre- and 
post-intervention EPDS scores in relation to follow-up.  
Participants 
During the time of project implementation, 40 postpartum women presenting to a 
privately-owned pediatric clinic located in northeastern Indiana were eligible to participate in the 
project. Of the 40 eligible postpartum women, 37 consented to participate by completing the 
patient data form and the self-reported depression EPDS screening. However, only 30 women 
completed and submitted the questionnaire that included the patient data form and self-
reporting depression EPDS screening in its entirety. Seven women failed to submit the 
completed questionnaire or submitted an incomplete questionnaire to office staff and were 
excluded from further data analysis. As a result of the screening intervention, five women were 
referred to their OB/GYN or PCP due to their high risk for PPD identified on the EPDS with total 
scores greater than or equal to 10. During project implementation, all providers (physician, NPs 
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and PAs) understood the importance for practice change and eagerly participated in the 
process.  
Demographic characteristics for participants (N = 30) were analyzed using frequency 
statistics. Participants infant ages ranged from 1 month to 6 months with 33% of ages being 2 
months. The majority of participants were Caucasian (60%), reported having achieved an 
educational level of a high school diploma (56.7%) and earned an annual income of less than 
$25,000 (76.7%) (see Table 4.1). The majority of participants reported no significant past 
medical history, including any mental health disorders (60%) while the remaining 40% did report 
a history of a mental health disorder. There were 23.3% participants who received previous 
treatment but 76.6% denied previous treatment for any psychological conditions and had 
followed up with their OB/GYN for a medical examination during the postpartum period (56.7%) 
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Table 4.1  












   
Baby Age   
Mean/SD 2.6333/1.62912  
1 Month 9 30% 
2 Month 10 33.3% 
4 Month 8 26.7% 
6 Month 3 10% 
   
Race   
African American 7 23.3% 
Caucasian 18 60% 
Hispanic 5 16.7% 
Asian 0  




Less than $25,000 23 76.7% 
$25,000-$49,999 5 16.7% 
$50,000-$74,999 2 6.7% 
   
Highest Education   
Elementary 0  
High School 17 56.7% 
Some College 4 13.3% 
College Graduate 9 30% 
   
Medical History   
Depression 3 10% 
Postpartum Depression 2 6.7% 
Anxiety 1 3.3% 
Multiple History 6 20% 
None 18 60% 
   
Current Treatment   
Treatment 7 23.3% 
No Treatment 23 76.7% 
   
Type of Treatment   
Medications 7 23.3% 
Therapy 0  
No Treatment 23 76.7% 
 











Follow up with OB   
Yes 17 56.7% 
No 12 40% 
No answer 1 3.3% 
   
Follow-up Weeks Postpartum   
1-2 Weeks 1 3.3% 
3-4 Weeks 2 6.7% 
5-6 Weeks 14 46.7% 
7+ Weeks 1 3.3% 
No answer 12 40% 
   
Provider at Time of Visit   
MD 5 16.7% 
PA 11 36.7% 
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Figure 4.1. Infant ‘s Age  
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Figure 4.3. Yearly Income  
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Figure 4.5. Medical History 
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Changes in Outcomes 
 You’re Not Forgotten EBP project addressed the following PICOT question, “In 
postpartum women (P), how does the implementation of a screening and referral protocol (I) for 
postpartum depression in a pediatric setting affect mental well-being (EPDS scores) (O), as, 
compared to the current practice (C) over a twelve-week period (T)?” The primary outcome of 
risk for PPD was measured in participants using the EPDS at baseline during the 1, 2, 4 or 6 
months well child visit and again at 12 weeks post-intervention. Secondary outcomes, including 
participant demographics, different variables that could potentially affect EPDS scores and the 
pre and post-intervention EPDS scores in relations to follow-up.   
Statistical Testing and Significance  
Data was inputted into the Statistical Package for Social Sciences (SPSS) version 25 
software for analysis. The textbook entitled How to use SPSS: A step-by-step guide to analysis 
and interpretation by Cronk (2017) was used to guide the progression of data analysis and 
interpretation. With the guidance of a statistician student, a paired-samples t-test was used to 
compare the means of participant pre-and post-intervention EPDS scores. Participant 
demographic data was measured via frequency statistics. A one-way Analysis of Variance 
(ANOVA) test was conducted to identify project variables in relation to the effects on EPDS 
scores.  
Findings 
 Project findings indicated that there was significance with the overall primary outcome of 
participant EPDS scores pre- and post-intervention. Statistical significance was set at p < .05 for 
all analyses. Based on the analysis between variables measured there was a concession of 
significance and no significance in relation to the results of the EPDS scores. A Cronbach’s 
alpha was conducted to test reliability and validity of the EPDS screening tool and was found to 
be .855, which demonstrates good reliability and validity.    
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 Primary outcome.  The primary outcome of You’re Not Forgotten was to implement a 
PPD screening protocol within a pediatric setting. Doing so aided in the identification of at-risk 
mothers for PPD and providing educational information and a rescreening process to continue 
to monitor their mental health. The EPDS screening tool was utilized to identify women who 
were at risk for PPD. Participants were asked to rate their feelings over the past seven days 
using a 10-item Likert scale.  The responses on the EPDS instrument were summed into a total 
scored which identified if the participant was at high risk for PPD at two different intervals over a 
12-week timeframe. Total EPDS scores ranging from 0-9 were considered lower risk for PPD 
and scores of 10 or greater were considered at high risk for PPD. Furthermore, positive answers 
to question number 10 on the EPDS tool prompted immediate medical attention. A paired-
samples t-test was calculated comparing the mean of the pre-intervention EPDS total score to 
the mean of the post-intervention EPDS total score. The mean on the pre-intervention EPDS 
total score was 4.83 (4.65), and the mean of the post-intervention scores was 2.40 (3.54). A 
significant decrease from pre-intervention EPDS total score was found t(29) = 6.625, p < .001 
(see Table 4.3).  
 In additional to the paired-samples t-tests that were calculated for the EPDS total scores, 
paired-samples t-tests were also calculated for each individual item within the EPDS screening 
tool pre-intervention and post-intervention (see Table 4.3). Each question was scored based on 
the response of the participant, ranging from 0 to 3 scores, with a maximum of 30. A negative 
response was scored as 0, while a positive response was scored as either 1, 2, or 3 for 
questions 1, 2 and 4. While questions 3 and 5-10 were reversed-scored (see Appendix F).  
Question 1 “I have been able to laugh and see the funny side of things” mean was 0.03 (0.18) 
t(29) = 1.000, p > 0.05, Question 2 “I have looked forward with enjoyment to things” mean was 
0.07 (0.05) t(29) = 1.439, p > 0.05, Question 3 “I have blamed myself unnecessarily when things 
went wrong” mean was 0.47 (0.63) t(29) = 4.065, p < 0.05, Question 4 “I have been anxious or 
worried for no good reason” mean was 0.50 (0.73) t(29) =3.746, p < 0.05, Question 5 “I have felt 
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scared or panicky for no very good reason” mean was 0.30 (0.53) t(29) = 3.071, p < 0.05, 
Question 6 “Things have been getting on top of me” mean was 0.47 (0.68) t(29) = 3.751, p < 
0.05, Question 7 “I have been so unhappy that I have had difficulty sleeping” mean was 0.20 
(0.47) t(29) = 2.693, p < 0.05, Question 8 “I have felt sad or miserable” mean was 0.27 (0.45) 
t(29) = 3.247, p < 0.05, Question 9 “I have been so unhappy that I have been crying” mean was 
0.13 (0.35) t(29) = 2.112, p < 0.05 and Question 10 “The thought of harming myself has 
occurred to me” mean was 0.10 (0.31) t(29) = 1.795, p > 0.05. There was no significant 
difference in questions 1, 2 or 10, while the remaining questions had a significant difference in 
the responses pre and post-intervention.  
 Secondary outcomes. Secondary outcomes included analysis of general demographics 
and sample characteristics, the relationship between pre- and post-intervention EPDS scores 
and participant follow-up, as well as relationships among variables and EPDS scores. The 
participants (N = 30) were a diverse group of women ranging from different ethnicity 
backgrounds, social economic standing and education. Among this diverse group there were 
23.3% (n = 7) African Americans, 60% (n = 18) Caucasians and 16.7% (n = 5) Hispanics (see 
Table 4.1; also see Figure 4.2). Within this group 76.7% (n = 23) reported an annual income of 
less than $25,000, 16.7% (n = 5) had an income between $25,000-$49,000 and 6.7% (n = 2) 
earned between $50,000-$74,999 (see Table 4.1; also see Figure 4.3). With a variety of yearly 
incomes, highest educational level attained was also evaluated which ranged from high school 
graduate to college graduate. There was 56.7% (n = 17) of participants who graduated from 
high school, while 13.3% (n = 4) had some college education and 30% (n = 9) obtained a 
college degree (see Table 4.1; also see Figure 4.4). There was some medical history included 
in the demographic data collection to help support project implementation and success (see 
Table 4.1) including past medical history relating to mental health (see Figure 4.5) and 
treatment and follow up with an OB/GYN or PCP (see Figure 4.6) pre- and post-intervention. 
There were 40% (n = 12) of participants that reported having some history of mental disorder 
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and of those, 23.3% (n = 7) were treated with psychiatric medications. Of all of the participants 
(N = 30), 56.7% (n = 17) followed up with their OB/GYN or PCP during the postpartum period.  
 The relationship between the pre- and post-intervention EPDS total scores and follow up 
with OB/GYN or PCP indicates that receiving educational information as a result of the project 
intervention impacted the participants’ follow-up practices. A paired-samples t-test was 
calculated to compare the mean of the pre-intervention EPDS score to the mean of the follow up 
with OB/GYN or PCP, as well as the mean of the post-intervention EPDS score to the mean of 
the follow up with OB/GYN or PCP. The mean of the pre-intervention EPDS score was 4.83 
(4.65) and the mean of the pre-intervention OB/GYN or PCP follow-up was 2.67 (0.76). A 
significant decrease from the pre-intervention EPDS score to follow-up was found t(29) = 2.259, 
p < 0.05. While the mean of the post-intervention EPDS score was 2.40 (3.54) and the mean of 
the OB/GYN or PCP follow-up was 2.67 (0.76). No significant difference from post-intervention 
EPDS scores to follow-up was found t(29) = -0.348, p > 0.05.   
 Lastly, the effect of certain demographics on EPDS scores was a secondary outcome 
measured. The different demographic variables (race, yearly income, baby’s age, education 
level and medical history) were evaluated using a one-way ANOVA. A one-way ANOVA 
comparing the postpartum mother’s baby’s age to the EPDS score was conducted. There was 
not a significant effect on the postpartum mothers’ baby’s age on total EPDS score at the p < 
0.05 level for these conditions F(3,26) = 1.798, p > 0.05. Postpartum women who began the 
intervention when their baby was 1 month old scored a mean EPDS of 3.56 (3.84), 2 months old 
mean EPDS of 4.50 (4.88), 4 months old mean EPDS of 7.75 (4.83), and 6 months old mean 
EPDS of 4.83 (4.65). A one-way ANOVA comparing the participant’s race to the total EPDS 
score was conducted and there was no significant effect found F(2, 27) = 0.397, p > 0.05. 
Participants who were African American had a mean of 4.71 (5.06), those who were Caucasian 
had a mean of 5.33 (4.93) and those who were Hispanic had a mean of 3.20 (3.27). A one-way 
ANOVA comparing the participant’s yearly annual income to the total EPDS score was 
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conducted and there was no significant effect on the yearly annual income on total EPDS 
scores at the p < 0.05 for these conditions F(3, 27) = 1.403, p > 0.05. Participants who made 
less than $25,000 had a mean of 4.91 (4.69), those who made between $25,000 and $49,999 
had a mean of 6.40 (4.62) and lastly those who made between $50,000 and $74,999 had a 
mean of 0 (0). A one-way ANOVA comparing the participants highest educational level achieved 
to EPDS scores was conducted and there was no significant effect on the highest educational 
level achieved on total EPDS scores F(2,27) = 1.787, p > 0.05. The participants who graduated 
high school group mean was 5.88 (5.07), those who had some college experience had a mean 
of 5.75 (5.06) and those who graduated from college mean was 2.44 (2.88). Finally, a one-way 
between subjects’ ANOVA was conducted to compare the effect of past medical history on 
EPDS total scores. There was a significant effect of past medical history on EPDS total scores 
at the p < .05 level for the three conditions F(4, 25) = 3.121, p = 0.033. Post hoc comparisons 
using the Tukey’s range test, also known as the honestly significant difference (HSD) test, 
indicated that the mean score for depression, M = 11.33 (.58), was significantly different than 
postpartum depression, M = 4.50 (6.36), and other variable outcomes M = 7.00, (6.63). Taken 
together, these results suggest that history of past medical disorders have an effect on EPDS 
total scores. Specifically, the results suggest that those who have suffered from any mental 
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Table 4.3 
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The results of You’re Not Forgotten EBP project provide direction for providers to screen 
for postpartum depression within a pediatric practice. The EBP project was intended to answer 
the following PICOT question, “In postpartum women (P), how does the implementation of a 
screening and referral protocol (I) for postpartum depression in a pediatric setting affect mental 
well-being (EPDS scores) (O), as, compared to the current practice (C) over a twelve-week 
period (T)?”.  The project examined the impact of the use of postpartum depression screening 
tools such as the EPDS tool to screen mothers during well-child visits to heighten awareness 
and identification of postpartum depression and mental wellbeing of mothers. This chapter will 
provide enlightenment and clarifications of the EBP project findings as well as provide an 
evaluation of the applicability of the EBP model used to guide this project. Strengths and 
limitations to the project will be discussed as well as implications for future practice, education, 
and research.  
Explanation of Findings 
 Project findings support the use of an effective postnatal depression screening tool 
within a pediatric setting. Such results were consistent with current evidence-based supportive 
literature. Project outcomes, including demographic characteristics and intervention data will be 
discussed. Outcomes including pre and post-intervention EPDS scores and the relationships 
between demographic characteristics and EPDS scores will be expanded upon. Additionally, 
participant adherence to follow-up recommendations provided during the intervention will be 
reviewed.   
Participant findings  
 Based on the information reported in the current literature a larger sample size was 
expected for this quality improvement project. The sample size for this project was limited for 
several contributing factors. These contributing factors included a limited intervention timeframe 
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as designated by the University where the project coordinator was enrolled and missed 
opportunities for screening within the practice. The intervention time frame of 12-weeks was not 
long enough to gather a large sample size, whereas supporting literature collected data for 
longer periods up to six months post-partum. Missed opportunities occurred due to the 
busyness of the clinic, increased workload of providers, and the project coordinator’s inability to 
be in the clinic daily for optimal recruitment of participants.  
Sample characteristics were as anticipated by the project coordinator including a 
population of completely female (100%) participants 18 years of age and older presenting to a 
pediatric office during the postpartum period. The majority of participants made less than 
$25,000 (76.7%) annually, which is below the median household income in northeast, Indiana 
(United States Census Bureau, 2018). Although the relationship between socioeconomic status 
and risk for PPD (EPDS scores) did not demonstrate significance in this project, evidence 
supports that those who earn less than $2,000 ($24,000/year) a month are at a higher risk for 
PPD (Sorgi, Coddington, Ahmed & Richards, 2019). Research also supports that postpartum 
women of low socioeconomic status are more likely to screen at high risk for PPD (Leis et al., 
2014; Friedman, Rochelson, Fallar & Mogilner, 2016). Demographic characteristics of 
participants from this project are consistent with the literature, indicating that participants who 
scored at high-risk for PPD (EPDS total score  10) earned less than $25,000 annually. 
Furthermore, another known contributor to socioeconomic status is educational level. Within this 
project, participant’s annual income correlated with their educational level. The majority of 
participants graduated with a high school diploma (56.7%) while only 43.3% either attended 
college or had a college degree. There was no relationship identified between education, or lack 
thereof, to EPDS total scores.  
 There were three main ethnicities represented within the project, African American 
(23.3%), Caucasian (60%) and Hispanic (16.7%). For this pediatric clinic, the project’s diverse 
sample was a good representation of the population frequenting the office for routine care. The 
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diverse ethnic backgrounds of the participants (N = 30) did not demonstrate a significant 
difference in their risk for PPD. Although a relationship between the project participants’ 
ethnicity and PPD was not found, researchers have reported that Hispanics are more likely to 
have positive PPD screenings (Sorgi, Coddington, Ahmed & Richards, 2019). Mothers 
participating in this study were recruited during well-child visits ranging from 1 month to 6 
months old, with the majority captured at the 2-month (33.3%) appointments. While there was 
no significant difference between the infant’s age and their mother’s EPDS scores in this 
project, Kurtz, Levine and Safyer (2017) discuss how the mother-infant relationship is impacted 
depending on the severity of the mothers’ symptoms. Other researchers have reported that 
mothers are more likely to screen positive for PPD at older well-child visits (i.e. 6 months) 
appointments rather than younger well-child appointments (i.e. 2 months and 4 months) 
(Emerson, Matthews & Struwe, 2018). On the contrary Sorg, Coddington, Ahmed and Richards 
(2019) found that mothers who were screened at 1-month well-child appointments were at 
higher risk for PPD than at 2- and 4-month appointments. Consequently, screening for PPD 
throughout the infant’s entire first year of life increases the probabilities of identifying positive 
(EPDS total score  10) EPDS scores.  
 Lastly, each participant in this project identified whether they have had any past or 
current history of a mental health condition. There was a total of 12 (40%) participants that 
identified having a positive history of a mental illness. Within this sample subset, half expressed 
having multiple mental illnesses including depression, postpartum depression and/or an anxiety 
disorder. Kurtz, Levine and Safyer (2017) suggest that those suffering from mental illnesses 
have a higher chance of screening positive for PPD than those without, which can negatively 
impact the infant’s health. Within this project, there was a significant association between a 
reported history of mental illness and high-risk EPDS total scores. Thus, screening women who 
have a past medical history of a mental health disorder for PPD during the postpartum period is 
of the utmost importance.  
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EPDS scores & follow up 
 During the implementation process of the project, participants were screened for their 
risk for PPD during their infant’s well-child visits and received a 12-week follow-up phone call for 
re-screening by the project coordinator following the intervention. Five participants met the 
criteria outlined within the EPDS screening tool (EPDS total score  10) for referral to their 
OB/GYN or PCP based on their initial screening results. During this 12-week implementation 
process, the project coordinator evaluated participants EPDS total scores pre-intervention, 
compliance of referral and post-intervention EPDS total scores. There was a significant 
difference between the initial pre-intervention EPDS scores, and post-intervention participant 
follow up with OB/GYN or PCP. The relationship between initial pre-intervention EPDS total 
scores and post-intervention follow up with an OB/GYN or PCP indicates that those that needed 
to follow up with their providers did so with success. Although there was a significant difference 
between the pre-intervention EPDS scores and follow-up, there was not a significant difference 
between post-intervention EPDS scores and follow up. These findings indicate that participants 
that followed up with their OB/GYN or PCP did not have an impact on their post-intervention 
EPDS scores. Though there was not a significant difference, each participant (n = 5) that 
screened positive on the pre-intervention screening, screened lower than their initial score on 
the 12-week follow-up.  
Pre- & Post-Intervention EPDS scores 
 The primary outcome of this project was to determine if screening for PPD within a 
pediatric setting is effective at identifying at-risk mothers during well-child visits. The paired 
samples t-test indicated that there was a significant decrease (p < .001) in EPDS scores from 
pre-intervention to post-intervention. The mean of the pre-intervention EPDS score was 4.83 
while the mean of the post-intervention EPDS score was 2.40, which is a difference of 2.43. 
These results imply that participants scored lower on their post-intervention screening than their 
initial pre-intervention screening (Table 4.2) After participants received PPD educational 
YOU’RE NOT FORGOTTEN  56 
 
information, discussion with their child’s pediatric provider about PPD and their  risk for the 
condition, follow-up with their OB/GYN or PCP, and a follow-up phone call with project 
coordinator occurred. These interventions likely increased the management of their PPD risk 
which was reflected in their 12-week post-intervention EPDS total scores. At the 12-week post-
intervention follow-up, 23.3% of participants verbalized the use of medication to help manage 
PPD.  
Strengths and Limitations of the DNP Project 
 Overall, the main objectives of this EBP project and successful implementation of the 
planned interventions were accomplished. Although there were a variety of strengths noted 
throughout this project there were also some limitations identified. Identifying and addressing 
each strength and limitation aides in the facilitation of best practice in the identification and 
management of postpartum depression.   
Strengths 
A strength of the project was the follow-up protocol set in place for participants who 
scored positive (EPDS total score  10) on the EPDS screening tool. There was a 2-week 
follow-up phone call conducted by the project coordinator for those who scored positive to 
ensure they received the necessary support and management for their level of PPD risk. This 
follow-up phone call allowed participants the opportunity to provide feedback about the 
screening process and provide data post-intervention to calculate their PPD risk. Another 
strength identified during project analysis included the benefit of providing PPD education and 
resources to participants. Educational and resource materials administered during project 
implementation heightened participant awareness of PPD and their potential risk for the 
condition, especially because many of the participants were not screened prior to the visit to 
their pediatrician’s office. Engaging participants with a list of supportive local resources for PPD 
ensured that they had the information necessary to seek assistance and medical intervention if 
desired. These resources included free counseling centers and low cost/ noninsured centers for 
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the public. These resources provided the participants with an alternative to visiting their 
OB/GYN or PCP, which could essentially reduce costs for treatment or therapy and be more 
convenient for participants to utilize. Utilizing the ACE Star Model was a great strength for this 
project by providing guidance for the development, implementation and evaluation of the 
project. Applying the five different stages of knowledge transformation into the project 
implementation, made transitioning research into practice at the project site practicable. 
Moreover, the uniqueness of the model helped create new knowledge within the project site for 
providers and participants.  
Limitations  
 A small sample size was identified as a limitation to this project which resulted from the 
recommended participant population by the AAP as well as the site facilitator’s time constraints 
for recruitment and implementation. The intervention timeframe limited the sample size due to 
the short amount of time to gather information, whereas AAP recommends participants being 
screened during all of the well-child visits within the first year of an infant’s life. Participants were 
recruited when presenting to the clinical setting for their child’s well-child visit during the 
postpartum period. Project recruitment was low due to a turnover in staff at the clinic site 
causing an increased emphasis on training new staff and reduced efforts at promoting the 
project. Recruitment of participants and implementation of the project interventions were best 
facilitated when the project coordinator was present in the clinic setting during two days each 
week and responsible for these activities. However, it was not feasible for the project manage to 
be present in the clinic on a daily basis and therefore it is likely that the recruitment efforts were 
not adhered to as well by healthcare providers during the project coordinator absence. Because 
providers were busy during the project implementation timeframe, it is likely that some potential 
participants were missed on the days that they were responsible for recruiting participants. The 
sample size was also limited by excluding adolescent mothers younger than 18 years of age 
and fathers of infants. Finally, the follow-up and recording of mother EPDS scores within the 
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EMR of their child at the clinic site by the providers was not completed as planned. The lack of 
compliance by the healthcare providers in documenting this information may be attributed to the 
overall large volume of patients encountered on a typical day and limited time for visits. 
Furthermore, a new EMR system was launched simultaneously with project implementation 
further complicating this process. As a result, the MAs provided PPD education and community 
resources information to the participants and informed the healthcare providers verbally of the 
mother’s EPDS total score prior to the well-child visit. This lack of formalized process for 
documenting mother’s EPDS total score had weaknesses which can contribute to human error. 
The reporting MA could notify the healthcare provider of the wrong results, provide the results to 
a different participant or interpret the results incorrectly. This can be improved by utilizing a 
completely electronic process including the EPDS screening tool being in electronic format that 
automatically inputs data and scores into the well-child visit chart. This can help eliminate 
human error and provide a more accurate result.   
Implications for the Future 
 The You’re Not Forgotten project provided prodigious information for APRN profession in 
relation to screening mothers at risk for PPD within a pediatric setting. Future implications for 
practice, theory, research and education will be explored here. These implications can be used 
to guide future EBP projects as well as address the stigma associated with depression and 
mental health disorders among our society.  
Practice 
 Current high-quality literature suggests that screening mothers for PPD within a pediatric 
setting is best practice. Although it is expressed to be best practice, unfortunately many 
pediatric offices are not implementing this practice. This project allowed for PPD screening to 
become a part of the standardized practice at the project site in hopes that this could provide 
support for all pediatric offices to adopt this protocol. The project intervention was very feasible 
and cost-effective for the pediatric site. There was no expense to the pediatric office in regard to 
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the postpartum depression screening tool since the project coordinator covered all printing 
finances. Therefore, additional planning would be necessary to determine how patients will have 
access to the screening tool and whether an electronic or paper format would be considered for 
future practice. Potential options for EPDS screening at the project site in the near future that 
providers at this setting have discussed include an electronic version of the screening tool with 
pre-existing tablets utilized by the office for patients and/or the printing of a free version of the 
screening tool from online resources.  The electronic version of the screening tool will go directly 
in the infant’s chart, while a paper form will be scanned into the chart and the actual form 
destroyed. Sustainability is being considered for an electronic version, which will be completed 
during well-child visits up to 12 months and recorded by the mother on tablets located in exam 
rooms.  
 For future EBP projects related to PPD screening within a pediatric setting, larger 
participant sizes, longer implementation times, and more detailed follow-up on the referral 
process for mothers at risk would be beneficial. Additional recommendations for future projects 
include following participants consistently throughout the project at multiple intervals over a 
longer course of time. This would aide in the ability to properly track participants over a 6-month 
period with each well-child visit to ensure effectiveness of screening within a pediatric setting.  
Theory 
The ACE Star Model was determined to be a good fit for this EBP project. Although the 
project coordinator was a novice at implementing new knowledge/protocols within a practice, 
the five stages of the ACE Star Model aided in the guidance of achieving successful practice 
changes by helping overcome challenges that accompany change. The ACE Star Model 
encompasses five stages:  discovery research, evidence summary, translation to guidelines, 
practice integration and process, and outcome evaluation (Melnyk & Fineout-Overholt, 2015). 
Each stage was utilized and relevant to the project development, implementation and 
evaluation. The foundation of the EBP project was essentially formed using the discovery 
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research stage, by inquiring what practice change was needed and to conduct a literature 
search. Recently having experienced childbirth and caring for an infant, the project coordinator 
realized screening for PPD was commonly only performed at the 6-weeks follow up postpartum 
visit with an OB/GYN. After questioning what happens to mothers who have PPD symptoms 
well after 6 weeks postpartum and pondering if anyone would notice, the project coordinator 
found strong evidence supporting the need for a change. Upon further investigation on the topic 
a lack of awareness and follow-up/referrals was also noted to be a problem. Evidence was 
reviewed during the evidence summary stage of the model, which indicated good and high 
quality/levels of evidence to support the project. During these stages as well as the translation 
to guidelines stage, the project coordinator determined how to properly utilize the supporting 
evidence in a beneficial manner manager for patient outcomes.  
There were modifications that occurred during the practice integration and change 
process of the ACE Star Model. For example, the project coordinator initially wanted screening 
to be done electronically to reduce the chance of error, but the project site was unable to 
account for electronically screening participants. It was originally planned for the participants to 
use a tablet to complete the EPDS screening and the score was to automatically translate to 
their child’s EMR. Due to the EMR system changes prior to implementation accommodations to 
utilize the paper form were made. Another modification that occurred during the practice 
integration phase of the project was the utilization of the secretarial staff to recruit eligible 
participants rather than the healthcare providers as initially planned. This modification benefited 
the project by reducing missed opportunities. Having the secretarial staff provided the 
screenings, aided in the reduction of missed opportunities but did not eliminate missed 
opportunities. The secretarial staff deem to be more suitable to provide the PPD screening 
along with other office paperwork.  
During the evaluation stage of the ACE Star Model it was very helpful to revisit the goals 
of the project and adoption of the practice protocol. Overall, the project was implemented with 
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minimal modifications while still achieving the outcomes desired. After completion of the 
implemented protocol, adoption of the project was discussed with the project site facilitator. As a 
result, strategies for incorporating the EPDS screening tool within the EMR are being 
considered. In congruency with the guidelines provided by AAP, it was discussed that the best 
way to adopt this protocol would be to screen participants at well-child visits up to a year of the 
infant’s life and provide participants with PPD education and community resources. Resources 
will be provided to participants based on the provider’s discretion. Future plans may include all 
parents (male or female) included in the screening during well-child visits at all pediatric 
facilities. Future research is needed for screening protocols for the lesbian, gay, bisexual, 
transgender and queer (LGBTQ) community and other legal guardians’ situations (i.e. adoption 
and fostering). Considerations for future implementations at the pediatric project site include 
strengthening OB/GYN and pediatrician relationships.  
Research 
 Further research is needed to explore the effects of screening for PPD in a pediatric 
setting in comparison to standard practice of screening in an OB/GYN or PCP office. It may be 
that screening for PPD in a pediatric setting identifies more at-risk mothers during the 
postpartum period in comparison to screening in an OB/GYN or PCP office. However, screening 
for PPD in an OB/GYN or PCP office is useful in reducing barriers associated with receiving 
treatment such as the lack of an available therapist, public treatment options, time constraints 
and patient reluctance. Thus, screening for PPD within a pediatric setting is beneficial for those 
who may not follow up with their OB/GYN or PCP postpartum and may be potentially missed. 
Screening in pediatric offices does not have to replace OB/GYN or PCP screenings but rather 
enhance encounters for screening PPD in general. If screenings are positive (EPDS total score 
 10) in a pediatric setting recommendation for referrals to an OB/GYN or PCP are enforced.   
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Education 
 Patient education is an essential role of the advanced practice registered nurse. 
Educating participants about the best practices, signs and symptoms of PPD, purpose of 
screening and available community resources was incorporated into the implemented protocol 
within this project. Education was the main focus on the PPD information which was provided 
for all participants, to ensure they were informed about PPD and its consequences. Participants 
expressed an increase of knowledge about PPD and great use of the reliable community 
resources. With the information the participants received, they expressed that it allowed them to 
be well-informed of their options available for assistance and support. Provider education is 
important regarding treatment and management of PPD. For instance, providers can shine 
some light on how to manage or provide different coping techniques for PPD. This project 
helped providers familiarize themselves with community resources, educate participants, and 
support and assisting participants with their individual needs. Implications for further research 
can include the impact of mother’s mental health effects on the mother-infant dyad. Research is 
needed to further educate providers regarding the benefits of screening women during the 
postpartum period at well-child visits in relations to child development.  
Conclusion 
 The You’re Not Forgotten project has enhanced the site facilitator, staff, and project 
participants understanding of the value of screening for PPD within a pediatric setting. The site 
facilitator expressed satisfaction with the project’s impact on the clinic and a desire to continue 
to screen mothers for PPD at this practice. Methods for sustainability are underway at the 
project site with possible incorporation into the new EMR system with appropriate staff training. 
The project facilitator was receptive to continued used of educational information aids including 
the use of the EPDS screening tool to disperse to eligible patients. The project site facilitator 
plans to follow the guidelines of the AAP and provide PPD screening to eligible mothers with a 
referral protocol for individuals who are at higher risk. During the 12-week post-intervention 
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phone call, participants also expressed their satisfaction of being screened for PPD in a 
pediatric setting, while many did not follow up with their own OB/GYN or PCP.  
 In conclusion, results of this project support the effectiveness of screening mothers for 
PPD in a pediatric setting and are consistent with the current literature. There was a significant 
difference in PPD risk scores from participants who were screened pre-intervention and re-
screened post-intervention. While there was no statistical significance on the demographic 
characteristics and EPDS scores within this project, larger sample studies have supported that 
those who suffer from any mental illness have a higher risk of screening positive for PPD.  
 Patient education and appropriate referral protocol procedures are an essential 
component for best practice protocols which should be in place to ensure patients are receiving 
the proper treatment needed.  Hence, this project has initiated a patient-centered practice 
change that will continue to positively impact the mother-infant dyad. It is recommended that 
providers incorporate this screening process within their practices to help individuals who are at 
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Patient Consent and Authorization Form 
Date: ___________      Identification #:________ 
PATIENT CONSENT AND AUTHORIZATION FORM 
 
Project Title: You’re Not Forgotten: The Effects of Screening Postpartum Depression in a 
Pediatric Setting 
 
Project Coordinator: Marrisa Culver, BSN, RN, DNP Student, Valparaiso University College of 
Nursing  
 
Purpose: I, _____________________________________________ (please print), understand 
that I am being asked to participate in an educational intervention project for postpartum 
mothers which will screen for postpartum depression in a pediatric setting.  
 
Procedure: The project coordinator will provide the following: an Edinburgh Postnatal 
Depression Screening tool (English or Spanish) during well child visits. The screening tool used 
is recommended by the American Academy of Pediatrics and the United States Preventive 
Services Task Force. 
 
Risk: There are no known physical risks to participate in this project. There are no invasive 
techniques or procedures used. This project is designed to increase knowledge and awareness 
of postpartum depression and to identify postpartum depression within a pediatric setting. The 
project involves collection of information from participants prior to seeing the physician, based 
on the score, educational information may be provided or possibly referral to obstetric (OB) 
doctor or primary care provider (PCP).   
 
Benefits: Identifying postpartum depression can decrease its effects on mother and baby. The 
knowledge gained from this project could provide valuable information regarding postpartum 
depression and its screening in a pediatric setting for health care providers, educators and 
health organizations. The program could possibly minimize missed opportunities for screenings.  
 
Payment for participation: I understand that I will not be paid for my participation in this 
project. I may receive free educational brochures and community resources.  
 
Additional Cost: I understand there will be no cost for me to participate in this project.  
 
Voluntary Participation/Withdrawal: I understand that my participation in this project is my 
choice and I am free to stop at any time without penalty.  
 
Questions: If I have any questions about my participation in the project or in the future, Marrisa 
Culver may be contacted at 219-895-8650 or through her email address at 
marrrisa.culver@valpo.edu. If you have questions about my rights as a project participant, 
Rasha Abed, Associate Director of the Institutional Review Board at Valparaiso University, may 
be contacted at (219) 464-5798.  
 
Confidentiality/Anonymity: Although information that I will give on the screening tool 




would identify me will be kept strictly confidential. I have been assured of my anonymity I the 
reporting of data.  
 
Consent to Participant in Project Study: I have read or had read to me all of the above 
information about this project, the procedure, possible risk, and potential benefits and I 
understand them. All of my questions have been answered. I give consent and permission freely 
to participate in this project. 
 
 
Participants Signature       Date 
 
_________________________________     _________________ 
 
Project Coordinator’s Signature      Date 
 









































Personal Data Form 
 
PERSONAL DATA FORM 
Name:  
Baby DOB or age?:  
Mother Race: 
 
Mother yearly income level (circle one that applies):  less than $25,000   $25,000-$49,999  
$50,000-$74,999   $75,000+    
  
Highest educational level achieved (circle one that applies):  Elementary  High School  Some 
College  College Graduate  Graduate School 
 
Past medical history of (circle all that apply): depression, post-partum depression, anxiety, mood 
disorders, other _____________ 
 
Current under treatment for depression or other psychological disorder? Yes or No   If Yes, 
explain_____________________________________________________ 
 
Follow up with OB provider since delivery?  Yes or No  Identify how many weeks postpartum.  
 
 













Provider seeing today: MD    PA    NP 
 
I, ______________________________________ give permission to the project coordinator 
and/or healthcare provider to contact my provider regarding the results of my screening.  
If the results of my screening indicate a high risk for depression, I give my permission for the 
project coordinator to contact me within 2 weeks of my visit via telephone to follow-up on my 
symptoms.  YES or NO 
 
 














Community Resource Listing 
Fort Wayne Community Resource Listing 
Name Contact Information 
Mental Health America of Northeast 
Indiana 
1027 W. Rudisill Blvd. Fort Wayne, IN 46807 
(260) 422-6441 
Cross Connections Inc. 4618 East State Blvd. Suite 300 Fort Wayne, 
IN 46815  
(260) 373-0213 
The Peggy F. Murphy Community Grief 
Center 
5920 Homestead Rd. Fort Wayne, IN 46814 
(260) 435-3261 or toll-free (800) 288-4111 
Park Center Walk-in Clinic 2710 Lake Ave. Fort Wayne, IN 46805 
(260)471-9440 or (260) 969-8440 
Suicide National Hotline (800) 273-8255 
Park Center (260) 481-2700 or (866) 481-2700 
Parkview Behavioral Health (260) 373-7500 or (800) 284-8439 
 
 
 
 
 
 
 
 
 
